REFERENCES
- Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Human Pathol. 1972;3:457–558.
- Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979; 43:360–373.
- Fauci AS, Haynes BF, Costa J, Lymphomatoid granulomatosis: prospective clinical and therapeutic experience over ten years. N EngI J Med. 1982;306:68–74.
- Koss M, Hochholzer L, Langloss JM, Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients. Pathology. 1986;18:283–288.
- Mizuno T, Takanashia Y, Onodera H, A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion with long clinical course and diffuse brain involvement. J Neurol Sci. 2003; 213:67–76.
- Kerslake R, Rowe D, Worthington BS. CT and MR imaging of CNS lymphomatoid granulomatosis. Neuroradiology. 1991;33:269–271.
- Tateishi U, Terae S, Ogata A, MR imaging of the brain in lymphomatoid granulomatosis. Am J Neuroradiol. 2001;22:1283–1290.
- Patsalides AD, Atac G, Hedge U, Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology. 2005;237:265–273.
- Kiryu S, Okubo T, Takeuchi K, Magnetic resonance imaging and diffusion tensor analysis of lymphomatoid granulomatosis of the brain. Acta Radiol. 2006;47:509–513.
- Kawai N, Miyake K, Nishiyama Y, FDG-PET findings of the brain in lymphomatoid granulomatosis. Ann Nucl Med. 2006;20:683–687.
- Nishihara H, Nakasato M, Sawa H, A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings. J Neurooncol. 2009;93:275–278.
- Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 1984;2:413–426.
- Lipford EH Jr, Margolick JB, Longo DL, Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674–1681.
- Nicholson AG, Wotherspoon AC, Diss TC, Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology. 1996;29:317–324.
- Taniere P, Thivolet-Bejui F, Vitrey D, Lymphomatoid granulomatosis—a report on four cases: evidence for B phenotype of the tumoral cells. Eur Respir J. 1998;12:102–106.
- Nishihara H, Tateishi U, Itoh T, Immunohistochemical and gene rearrangement studies of central nervous system lymphomatoid granulomatosis. Neuropathology. 2007;27;413–418.
- Lucantoni C, De Bonis P, Doglietto F, Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol. 2009;94:235–242.
- Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist. 2008;13:577–585.
- Jaffe ES, Wilson WH. Lymphomatoid granulomatosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumors: Pathology and Genetics, Tumors of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:185–187.
- Wilson WH, Kingma DW, Raffeld M, Association of lymphomatoid granulomatosis with the Epstein Barr virus infection of B lymphocytes and response to interferon alpha 2β. Blood. 1996;87:4531–4537.
- Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. 2004;45:777–780.
- Petrella TM, Walker IR, Jones GW, Leber B. Radiotherapy to control CNS lymphomatoid granulomatosis: a case report and review of the literature. Am J Hematol. 1999;62:239–241.
- Healey Bird BR, Grant N, Dunleavy K, Treatment and biology of lymphomatoid granulomatosis. Proc Am Soc Clin Oncol. 2007;25:18S (abstract no. 8029).